Gabather AB: Difference between revisions
>Paris Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was incorporated in 2014 and is based in Södertälje Sweden. == References and notes == Category:Thesis __INDEX__" |
(No difference)
|
Latest revision as of 05:09, 16 August 2022
Summary[1] edit edit source
Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was incorporated in 2014 and is based in Södertälje Sweden.
References and notes edit edit source
- ↑ Source: Yahoo Finance.